Pharmaceutical Preparations — 456 US public companies

Total revenue (latest)

—

Total net income

—

Avg net margin

—

Median net margin

—

5-year industry trend

Total revenue summed across 102 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.

Largest by revenue

Revenue Market cap Net income Net margin

Insider activity in this industry · last 12 months

Insider buying

$16.0M

Insider selling

$80.08B

Net flow

−$80.07B

Distinct insiders

92

Open-market trades summed across all 7 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.

Recently filed in this industry

LABT Lakewood-Amedex Biotherapeutics Inc.
Filed 2026-05-22
10-Q
BPTH BIO-PATH HOLDINGS, INC.
Filed 2026-05-20
10-Q
ROIV Roivant Sciences Ltd.
Filed 2026-05-20
10-K
ACET Adicet Bio, Inc.
Filed 2026-05-20
10-K
CPMD CANNAPHARMARX, INC.
Filed 2026-05-20
10-Q/A
JAGX Jaguar Health, Inc.
Filed 2026-05-20
10-Q/A
BPTH BIO-PATH HOLDINGS, INC.
Filed 2026-05-20
10-Q/A
ADTX Aditxt, Inc.
Filed 2026-05-20
10-Q
CPMD CANNAPHARMARX, INC.
Filed 2026-05-20
10-Q
JAGX Jaguar Health, Inc.
Filed 2026-05-20
10-Q
AKTX Akari Therapeutics Plc
Filed 2026-05-19
10-Q/A
ORMP ORAMED PHARMACEUTICALS INC.
Filed 2026-05-19
10-Q

Related industries

Biological Products, (No Diagnostic Substances)

SIC 2836 · 25 cos

Industrial Organic Chemicals

SIC 2860 · 5 cos

Chemicals & Allied Products

SIC 2800 · 4 cos

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)

SIC 2820 · 2 cos

Plastic Materials, Synth Resins & Nonvulcan Elastomers

SIC 2821 · 2 cos

Miscellaneous Chemical Products

SIC 2890 · 2 cos

Agricultural Chemicals

SIC 2870 · 1 cos

Medicinal Chemicals & Botanical Products

SIC 2833 · 1 cos

About the Pharmaceutical Preparations industry on ActaClear

ActaClear tracks 456 US-listed public companies classified under SEC SIC code 2834 (Pharmaceutical Preparations).

Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.